@article{TP155993,
author = {Jing Chen and Yishuo Sun and Xiaona Hou and Xingjiao Fu and Xiaoxiao Chen and Qiang Zhang and Dandan Wang and Xiaojun Zhang and Xue Liu and Jingxia Hao},
title = {Efficacy and influencing factors of recombinant human growth hormone therapy in children with Turner syndrome: a single-center retrospective cohort study},
journal = {Translational Pediatrics},
volume = {15},
number = {6},
year = {2026},
keywords = {},
abstract = {Background: Real-world evidence regarding the optimal initiation timing and safety of recombinant human growth hormone (rhGH) in children with Turner syndrome (TS) remains limited. This study aimed to evaluate the efficacy of rhGH therapy in children with TS and to identify clinically relevant factors influencing treatment outcomes, thereby providing evidence to inform individualized therapeutic strategies.Methods: This retrospective cohort study included 50 pediatric patients with TS (3–14 years) who received rhGH therapy for ≥6 months. Eligibility criteria included a confirmed TS karyotype and height },
issn = {2224-4344}, url = {https://tp.amegroups.org/article/view/155993}
}